TNSN91049A1 - Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique - Google Patents

Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique

Info

Publication number
TNSN91049A1
TNSN91049A1 TNTNSN91049A TNSN91049A TNSN91049A1 TN SN91049 A1 TNSN91049 A1 TN SN91049A1 TN TNSN91049 A TNTNSN91049 A TN TNSN91049A TN SN91049 A TNSN91049 A TN SN91049A TN SN91049 A1 TNSN91049 A1 TN SN91049A1
Authority
TN
Tunisia
Prior art keywords
carbon atoms
processes
preparation
pharmaceutical use
atoms
Prior art date
Application number
TNTNSN91049A
Other languages
English (en)
French (fr)
Inventor
Elof Brandstrom Arne
Lennart Lindberg Per
Elisabeth Sunden Gunnel
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN91049A1 publication Critical patent/TNSN91049A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
TNTNSN91049A 1990-06-20 1991-06-19 Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique TNSN91049A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds

Publications (1)

Publication Number Publication Date
TNSN91049A1 true TNSN91049A1 (fr) 1992-10-25

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN91049A TNSN91049A1 (fr) 1990-06-20 1991-06-19 Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique

Country Status (27)

Country Link
EP (1) EP0535081A1 (enExample)
JP (1) JPH05507713A (enExample)
CN (1) CN1058212A (enExample)
AP (1) AP215A (enExample)
AU (1) AU649453B2 (enExample)
BG (1) BG97200A (enExample)
CA (1) CA2083714A1 (enExample)
CZ (1) CZ279772B6 (enExample)
FI (1) FI925766A0 (enExample)
HU (1) HUT62881A (enExample)
IE (1) IE912025A1 (enExample)
IL (1) IL98470A0 (enExample)
IS (1) IS3721A7 (enExample)
LT (2) LT3952B (enExample)
LV (1) LV10953A (enExample)
MA (1) MA22199A1 (enExample)
NO (1) NO924775L (enExample)
NZ (1) NZ238546A (enExample)
OA (1) OA09682A (enExample)
PT (1) PT98035A (enExample)
RO (1) RO110493B1 (enExample)
SE (1) SE9002206D0 (enExample)
TN (1) TNSN91049A1 (enExample)
TW (1) TW216418B (enExample)
WO (1) WO1991019711A1 (enExample)
YU (1) YU104191A (enExample)
ZA (2) ZA914296B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
CA2400953A1 (en) 2000-02-24 2001-08-30 Kopran Research Laboratories Limited Orally administrable acid stable anti-ulcer benzimidazole derivatives
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
DE60325709D1 (de) 2002-04-09 2009-02-26 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
KR20060092255A (ko) 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
ES2511792T3 (es) 2006-07-25 2014-10-23 Vecta Ltd. Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP
US20110009624A9 (en) * 2006-10-13 2011-01-13 Masato Ueda Benzimidazole compounds having gastric acid secretion inhibitory action
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
KR102409502B1 (ko) 2016-09-14 2022-06-16 위펑 제인 쳉 D-아미노산 옥시다제 (daao) 저해제로서 신규한 치환된 벤즈이미다졸 유도체

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (enExample) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
MY103790A (en) * 1987-10-30 1993-09-30 Ab Hassle Novel compound for the treatment of several bone affecting diseases
JPH03501609A (ja) * 1987-12-11 1991-04-11 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規ベンゾイミダゾール誘導体
JPH03504497A (ja) * 1988-05-25 1991-10-03 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規フルオルアルコキシ化合物

Also Published As

Publication number Publication date
AU649453B2 (en) 1994-05-26
LV10953A (lv) 1995-12-20
CN1058212A (zh) 1992-01-29
IE912025A1 (en) 1992-01-01
LT3952B (en) 1996-05-27
NO924775D0 (no) 1992-12-10
IL98470A0 (en) 1992-07-15
LTIP1713A (en) 1995-08-25
YU104191A (sh) 1994-01-20
HU9204033D0 (en) 1993-03-29
CS189491A3 (en) 1992-04-15
SE9002206D0 (sv) 1990-06-20
PT98035A (pt) 1992-03-31
NZ238546A (en) 1994-03-25
FI925766A7 (fi) 1992-12-18
LT3977B (en) 1996-06-25
AP9100285A0 (en) 1991-07-31
LTIP1712A (en) 1995-08-25
WO1991019711A1 (en) 1991-12-26
CA2083714A1 (en) 1991-12-21
FI925766A0 (fi) 1992-12-18
NO924775L (no) 1992-12-10
RO110493B1 (ro) 1996-01-30
JPH05507713A (ja) 1993-11-04
ZA914296B (en) 1992-03-25
ZA914297B (en) 1992-03-25
AP215A (en) 1992-09-02
BG97200A (bg) 1993-12-24
EP0535081A1 (en) 1993-04-07
AU8009791A (en) 1992-01-07
TW216418B (enExample) 1993-11-21
IS3721A7 (is) 1991-12-21
OA09682A (en) 1993-05-15
MA22199A1 (fr) 1992-04-01
HUT62881A (en) 1993-06-28
CZ279772B6 (cs) 1995-06-14

Similar Documents

Publication Publication Date Title
TNSN91049A1 (fr) Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique
TNSN91050A1 (fr) Derives dialkoxy-pyridinyl-benzimidazole, procedes en vue de leur preparation, et leur emploi pharmaceutique
FR2439187A1 (fr) Derives de 1-piperazine-carboxamides et -carbothioamides substitues, procede de preparation et compositions pharmaceutiques les contenant
DE3827623C2 (de) Verfahren zur Herstellung von pharmazeutisch verwendbarem getrocknetem Regenwurmpulver und seine Verwendung als antihyperlipämische, antidiabetische, antihypertonische und antihypotonische Zubereitung
TNSN97110A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97015A1 (fr) Nouveaux derives de 19-nor-pregnene.
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
BE904796A (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant.
BE905890A (fr) Anticorps monoclonaux a reaction croisee et protection croisee vis-a-vis des serotypes de p.aeruginosa.
FR2404634A1 (fr) Composes de thiazole et compositions pharmaceutiques en contenant
BE1000201A4 (fr) Composes antibiotiques, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2438654A1 (fr) Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose
FR2424259A1 (fr) Esters de l'acide ((trifluoromethyl-5 pyridyloxy-2)-4 phenoxy)-4 pentene-2 oique utiles comme herbicides
KR870007118A (ko) 광학적으로 순수한 화합물 및 그의 제조 방법
FR2455587A1 (fr) Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
TNSN95062A1 (fr) Nouveaux derives dialkoxy-pyridinyle-benzimidazole
DE69814473D1 (de) Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
KR920703082A (ko) 어류 질병의 예방 및 치료제
Hessler et al. Lethal toxoplasmosis in a woolly monkey
FR2450817A1 (fr) Nouveaux oxime-ethers comportant un groupe pyridinyle, leur preparation et leur application therapeutique
FR2449401A1 (fr) Additifs pour insecticides par ingestion et/ou photodegradables, compositions insecticides contenant ces additifs et procede de lutte contre les insectes
BE1002181A3 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances.
EP0378825A3 (fr) Esters alicycliques et leur utilisation à titre d'ingrédients parfumants
OA09665A (fr) Esters d'aminoacides de l'hydroquinone, leur procédé de préparation et compositions pharmaceutiques ou cosmétiques les contenant
BE1002121A4 (fr) Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation et medicaments les contenant.